Company / News & Insights / PRESS RELEASE: June 2021: Installation and validation of LIMS is complete in our Philadelphia site!

PRESS RELEASE: June 2021: Installation and validation of LIMS is complete in our Philadelphia site!

The installation and validation of our LabVantage Laboratory Information Management System (LIMS) is complete in our Philadelphia site!

 

Staff at our Philadelphia site worked together with cross-functional teams in Quality, Operations, IT, CSols, Inc. and LabVantage (vendor) to complete the installation and validation of a highly-functional and GMP compliant LIMS system. Lou Forcellini, site Quality Director in Philadelphia, says “This investment in a highly functional LIMS offers significant enhancements to our robust quality systems, providing enhanced compliance and improved data integrity”. Initial functionality includes:

  • Project and customer management
  • Sample management (initiation, receipt, handling, preparation, bar coding)
  • Test execution (data entry, test/analysis management)
  • Data management (review, approval, reporting, search)
  • Stability management
  • Laboratory consumables management (reagents, standards, prepared solutions, columns)
  • Audit Trails

 

The move to Labvantage will a provide standard templates for the reports and Certificates of Analysis we deliver to our clients. While fewer custom report formats will be available, the long-term benefits of the system will far outweigh any short-term impact on reports. “The LabVantage platform offers many immediate benefits to our customers and to our internal operations. The potential for future enhancements is exciting and positions us for growth as a valued partner to our many customers who are bringing new therapies to market” says Rob Tuohy, Vice President, Pharmaceutical Development. Potential future functionality includes:

  • Laboratory execution sheets (LES)
  • Electronic Laboratory Notebooks (ELN)
  • External testing request management
  • Task / event schedule management
  • Environmental monitoring/cleaning verification management
  • Analytical quality control (AQC) batch analysis/management
  • Instrumentation calibration and maintenance
  • Portal/external access capabilities
  • Analyst training tracking
  • Deviation/investigation/CAPA management

About Pace Analytical Life Sciences

Pace Analytical Life Sciences provides premier CDMO / CRO services, from 5 sites, working alongside Pharma & Biopharma innovators to advance new therapies to market. Our teams have proven expertise with small molecules, biologics (such as proteins, peptides, antibodies, antibody drug conjugates) and gene therapies (such as RNA and DNA oligos). Founded in 2006, Pace Analytical provides premier drug development services to advance candidates from early pre-formulation and tox studies to IND filings and on through the clinical phases. Our GMP clinical supplies manufacturing capabilities include sterile injectables, ophthalmics, capsules, tablets, solutions/suspensions, and topicals. Our early-phase CDMO sites are located in Woburn, Massachusetts, Salem, New Hampshire, and Philadelphia, Pennsylvania. Our FDA-registered laboratory testing facilities are located in Oakdale, Minnesota, and San German, Puerto Rico. We are dedicated to providing not only the best in pharmaceutical development and analytical testing services, but also the most reliable. We are well-equipped to handle almost any project regardless of scope or complexity. For more information, please visit Pace Life Sciences.

Sales Contact:
Arturo Cherena
Vice President Sales & Business Development
arturo.cherena@pacelabs.com

Media Contact:
Chelsea Robinson
Marketing Manager
chelsea.robinson@pacelabs.com